129 related articles for article (PubMed ID: 28395961)
1. Undifferentiated carcinoma of nasopharyngeal type in children: Clinical features and outcome.
Zrafi WS; Tebra S; Tbessi S; Ouni S; Jebsi M; Bouaouina N
Eur Ann Otorhinolaryngol Head Neck Dis; 2017 Oct; 134(5):321-324. PubMed ID: 28395961
[TBL] [Abstract][Full Text] [Related]
2. [Pediatric nasopharyngeal carcinoma: Anatomoclinic aspects, therapeutic results and evolutive particularities].
Frikha M; Toumi N; Ghorbel L; Ben Salah H; Khabir A; Karray H; Gargouri R; Boudawara T; Ghorbel A; Daoud J
Cancer Radiother; 2010 Jun; 14(3):169-75. PubMed ID: 20347607
[TBL] [Abstract][Full Text] [Related]
3. [Nasopharyngeal carcinoma in Tunisian children: retrospective epidemiological, clinical and biological study about 48 cases].
Jmal A; Boussen H; Ghanem A; Abaza H; Gara S; Douik H; Harzallah L; Benna F; Ladgham A; Guemira F
Bull Cancer; 2005 Nov; 92(11):977-81. PubMed ID: 16316831
[TBL] [Abstract][Full Text] [Related]
4. Nasopharyngeal carcinoma in childhood and adolescence: a single institution's experience with treatment modalities during the last 15 years.
Polychronopoulou S; Kostaridou S; Panagiotou JP; Stefanaki K; Papadakis V; Florentin L; Houlakis M; Christopoulos G; Haidas S
Pediatr Hematol Oncol; 2004; 21(5):393-402. PubMed ID: 15205082
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy.
Hua YJ; Han F; Lu LX; Mai HQ; Guo X; Hong MH; Lu TX; Zhao C
Eur J Cancer; 2012 Dec; 48(18):3422-8. PubMed ID: 22835782
[TBL] [Abstract][Full Text] [Related]
7. [Metachronous cancers after treatment for undifferentiated nasopharyngeal carcinoma].
Boussen H; Kochbati L; Oueslati Z; Gritli S; Daoud J; Gammoudi A; Besbes M; Bouaouina N; Benna F; Ladgham A; Maalej M
Ann Otolaryngol Chir Cervicofac; 2004 Nov; 121(5):282-5. PubMed ID: 15711481
[TBL] [Abstract][Full Text] [Related]
8. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group.
Chua DT; Sham JS; Choy D; Lorvidhaya V; Sumitsawan Y; Thongprasert S; Vootiprux V; Cheirsilpa A; Azhar T; Reksodiputro AH
Cancer; 1998 Dec; 83(11):2270-83. PubMed ID: 9840526
[TBL] [Abstract][Full Text] [Related]
9. Radiation and chemotherapy combination for nasopharyngeal carcinoma in children: Radiotherapy dose adaptation after chemotherapy response to minimize late effects.
Orbach D; Brisse H; Helfre S; Klijanienko J; Bours D; Mosseri V; Rodriguez J
Pediatr Blood Cancer; 2008 Apr; 50(4):849-53. PubMed ID: 17973328
[TBL] [Abstract][Full Text] [Related]
10. Undifferentiated nasopharyngeal cancer (UCNT): current diagnostic and therapeutic aspects.
Altun M; Fandi A; Dupuis O; Cvitkovic E; Krajina Z; Eschwege F
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):859-77. PubMed ID: 7790274
[TBL] [Abstract][Full Text] [Related]
11. Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type.
Fandi A; Bachouchi M; Azli N; Taamma A; Boussen H; Wibault P; Eschwege F; Armand JP; Simon J; Cvitkovic E
J Clin Oncol; 2000 Mar; 18(6):1324-30. PubMed ID: 10715304
[TBL] [Abstract][Full Text] [Related]
12. Nasopharyngeal carcinoma in childhood and adolescence: a single-institution experience with combined therapy.
Zubizarreta PA; D'Antonio G; Raslawski E; Gallo G; Preciado MV; Casak SJ; Scopinaro M; Morales G; Sackmann-Muriel F
Cancer; 2000 Aug; 89(3):690-5. PubMed ID: 10931470
[TBL] [Abstract][Full Text] [Related]
13. [Neoadjuvant chemotherapy with concurrent chemoradiotherapy in the treatment of nasopharyngeal cancer: Southern Tunisian experience].
Mnejja W; Toumi N; Fourati N; Bouzguenda R; Ghorbel A; Frikha M; Siala W; Daoud J
Bull Cancer; 2018 May; 105(5):450-457. PubMed ID: 29650393
[TBL] [Abstract][Full Text] [Related]
14. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma.
Chan AT; Teo PM; Leung TW; Leung SF; Lee WY; Yeo W; Choi PH; Johnson PJ
Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):569-77. PubMed ID: 7558945
[TBL] [Abstract][Full Text] [Related]
15. Treatment outcome of childhood nasopharyngeal carcinoma: A single institution experience.
Nikitovic M; Popovic-Vukovic M; Stanic D; Bokun J; Paripovic L; Ilic V; Miskovic I; Saric M
Int J Pediatr Otorhinolaryngol; 2018 Oct; 113():168-172. PubMed ID: 30173978
[TBL] [Abstract][Full Text] [Related]
16. Nasopharyngeal carcinoma: our experience.
d'Espiney Amaro C; Montalvão P; Henriques P; Magalhães M; Olias J
Eur Arch Otorhinolaryngol; 2009 Jun; 266(6):833-8. PubMed ID: 18830701
[TBL] [Abstract][Full Text] [Related]
17. Analysis of rare periparotid recurrence after parotid gland-sparing intensity-modulated radiotherapy for nasopharyngeal carcinoma.
Xu Y; Zhang M; Yue Q; Zong J; Lin J; Sun R; Qiu S; Lin S; Pan J
Cancer Radiother; 2016 Jul; 20(5):377-83. PubMed ID: 27372558
[TBL] [Abstract][Full Text] [Related]
18. Undifferentiated nasopharyngeal carcinoma in children: a report of four cases.
Barjaktarevic ZD; Golubicic IV
J Chemother; 1995 Jun; 7(3):249-52. PubMed ID: 7562023
[TBL] [Abstract][Full Text] [Related]
19. Encouraging Outcomes With Manageable Toxicity Using Neoadjuvant Chemotherapy and Intensity-modulated Radiotherapy in Advanced Pediatric Nasopharyngeal Carcinoma: Single-Center Experience From a Developing Country.
Das A; Mallick I; Arun P; Midha D; Sen S; Krishnan S; Bhattacharyya A
J Pediatr Hematol Oncol; 2017 May; 39(4):318-319. PubMed ID: 28234743
[No Abstract] [Full Text] [Related]
20. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.
Azli N; Fandi A; Bachouchi M; Rahal M; Lianes P; Wibault P; Boussen H; Eschwege F; Armand JP; Cvitkovic E
Cancer J Sci Am; 1995; 1(3):222-9. PubMed ID: 9166480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
